Rxi Pharmaceuticals Corporation

Patents = 16

Forward Citations = 656

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

14 inventors (with patents filed for the assignee):

RXi Pharmaceuticals Corporation is a biotechnology company focused on developing innovative RNAi-based therapeutics. Using its proprietary self-delivering RNAi (sd-rxRNA) technology platform, RXi aims to develop the next generation of RNAi therapy targeting a wide range of diseases. The company's sd-rxRNA compounds are designed to selectively silence disease-causing genes, offering potential treatment options for various conditions including cancer, dermatology disorders, and ophthalmology disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com